NASDAQ: TGTX
Tg Therapeutics Inc Stock Ownership - Who owns Tg Therapeutics?

Insider buying vs selling

Have Tg Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Yann EchelardDirector2025-11-245,000$32.57
$162.85kSell
Sagar LonialDirector2025-09-1120,852$32.24
$672.27kSell
Yann EchelardDirector2025-06-1310,000$36.94
$369.40kSell

1 of 1

TGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TGTX insiders and whales buy or sell their stock.

TGTX Shareholders

What type of owners hold Tg Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael S. Weiss21.14%33,760,975$1.24BInsider
Blackrock Inc13.68%21,848,462$800.09MInstitution
Vanguard Group Inc9.92%15,841,002$580.10MInstitution
Ra Capital Management LP7.91%12,629,868$462.51MInsider
Lindsay A. Md Rosenwald5.93%9,462,616$346.52MInsider
State Street Corp5.31%8,479,999$310.54MInstitution
Biotechnologies Sasu Lfb4.77%7,614,855$278.86MInsider
Joan Pons Gimbert2.48%3,959,149$144.98MInsider
Clearbridge Investments LLC2.16%3,448,033$126.27MInstitution
Geode Capital Management LLC2.13%3,403,866$124.65MInstitution

1 of 3

TGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TGTX58.07%41.93%Net Selling
SYRE75.86%24.14%Net SellingNet Selling
CGON85.41%14.59%Net BuyingNet Buying
MIRM53.72%46.28%Net BuyingNet Selling
PTCT86.56%13.44%Net SellingNet Selling

Tg Therapeutics Stock Ownership FAQ

Who owns Tg Therapeutics?

Tg Therapeutics (NASDAQ: TGTX) is owned by 64.59% institutional shareholders, 46.63% Tg Therapeutics insiders, and 0.00% retail investors. Michael S. Weiss is the largest individual Tg Therapeutics shareholder, owning 33.76M shares representing 21.14% of the company. Michael S. Weiss's Tg Therapeutics shares are currently valued at $1.19B.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.